Salona Global Medical Device Corp

Healthcare CA SGMD

NoneCAD
0.00(0%)

Last update at 2024-04-23T03:10:17.053828Z

Day Range

LowHigh

52 Week Range

0.150.50

LowHigh

Fundamentals

Previous Close -
Market Cap17.63M
VolumeNone
P/E Ratio-
Dividend Yield-%
Revenue TTM56.12M
Revenue Per Share TTM0.82
Gross Profit TTM 0.05M
Diluted EPS TTM-0.28

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2022-02-28	2021-02-28	2020-02-29	2019-02-28	2018-02-28
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-02-28	2021-02-28	2020-02-29	2019-02-28	2018-02-28
Income before tax	-4.47364M	-2.66742M	-1.76785M	-0.76057M	-7.92435M
Minority interest	-	-	-	-	-
Net income	-4.37202M	-2.66742M	-2.34135M	-0.76057M	-8.05964M
Selling general administrative	9.57M	2.29M	0.54M	1.73M	2.13M
Selling and marketing expenses	-	-	-	-	-
Gross profit	5.96M	-0.37978M	-1.18879M	0.97M	-5.67455M
Reconciled depreciation	0.84M	0.00000M	0.05M	0.26M	0.28M
Ebit	-	-	-	-	-
Ebitda	-3.24381M	-2.66742M	-1.67372M	-0.50453M	-7.52682M
Depreciation and amortization	-	-	-	-	-
Non operating income net other	-	-	-	-	-
Operating income	-4.45068M	-2.66742M	-1.72824M	-0.76057M	-7.80355M
Other operating expenses	-	-	-	-	0.08M
Interest expense	0.39M	0.00000M	0.00000M	0.00000M	0.00000M
Tax provision	-0.10162M	0.00000M	0.00000M	0.00000M	0.14M
Interest income	-	-	-	-	-
Net interest income	-0.38806M	-	-	-	-
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-0.10162M	-	-	-	0.14M
Total revenue	18.31M	-0.03355M	0.35M	3.15M	3.94M
Total operating expenses	22.76M	2.63M	2.08M	3.91M	11.74M
Cost of revenue	12.35M	0.35M	1.54M	2.18M	9.61M
Total other income expense net	0.37M	-1.64359M	-0.03961M	-	-0.12080M
Discontinued operations	-	-	-0.57350M	1.57M	1.57M
Net income from continuing ops	-4.37202M	-2.66742M	-1.76785M	-0.76057M	-8.05964M
Net income applicable to common shares	-4.37202M	-2.66742M	-1.92415M	-0.73430M	-6.61429M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2022-02-28	2021-02-28	2020-02-29	2019-02-28	2018-02-28
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-02-28	2021-02-28	2020-02-29	2019-02-28	2018-02-28
Total assets	42.68M	13.13M	9.33M	11.62M	11.37M
Intangible assets	6.93M	-	-	-	-
Earning assets	-	-	-	-	-
Other current assets	0.41M	5.56M	0.14M	0.50M	0.65M
Total liab	29.53M	6.49M	0.37M	0.41M	0.33M
Total stockholder equity	13.15M	6.64M	8.97M	11.21M	11.04M
Deferred long term liab	-	-	-	-	-
Other current liab	15.32M	5.44M	0.01M	0.01M	0.01M
Common stock	38.53M	31.07M	31.06M	31.06M	31.06M
Capital stock	38.53M	31.07M	31.06M	31.06M	-
Retained earnings	-33.36488M	-28.99286M	-26.32544M	-24.40129M	-23.66699M
Other liab	-	5.43M	-	-	-
Good will	9.83M	-	-	-	-
Other assets	0.48M	-	-	-	-
Cash	8.06M	7.08M	8.35M	9.30M	6.06M
Cash and equivalents	-	-	-	-	-
Total current liabilities	24.91M	6.49M	0.23M	0.28M	0.33M
Current deferred revenue	-	-	-	-	-
Net debt	-	-	-	-	-
Short term debt	-	-	-	-	-
Short long term debt	5.67M	-	-	-	-
Short long term debt total	-	-	-	-	-
Other stockholder equity	1.01M	0.94M	1.37M	1.21M	1.99M
Property plant equipment	5.40M	-	-	0.00587M	0.06M
Total current assets	20.04M	13.13M	8.89M	11.33M	12.37M
Long term investments	-	-	-	-	-
Net tangible assets	-3.60646M	6.64M	9.50M	11.06M	12.09M
Short term investments	0.00000M	0.49M	0.84M	-	-
Net receivables	6.60M	-	0.40M	1.53M	5.67M
Long term debt	0.68M	-	-	-	0.01M
Inventory	4.97M	-	-	-	-
Accounts payable	2.86M	0.48M	0.17M	0.19M	0.28M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	-	-
Deferred long term asset charges	-	-	-	-	-
Non current assets total	22.65M	0.00000M	0.00000M	0.19M	0.45M
Capital lease obligations	4.18M	-	-	-	-
Long term debt total	-	-	-	-	-

Breakdown	2022-02-28	2021-02-28	2020-02-29	2019-02-28	2018-02-28
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-02-28	2021-02-28	2020-02-29	2019-02-28	2018-02-28
Investments	0.50M	0.07M	-0.89941M	-0.89941M	-0.89941M
Change to liabilities	1.52M	0.88M	-0.04409M	-0.05967M	-0.83049M
Total cashflows from investing activities	-4.61754M	0.07M	-0.89941M	-0.89941M	-0.09281M
Net borrowings	-0.04364M	-0.04364M	-0.04364M	-0.04364M	-2.21375M
Total cash from financing activities	3.94M	5.43M	5.43M	5.43M	-2.45939M
Change to operating activities	-1.97102M	0.39M	0.79M	3.02M	4.66M
Net income	-4.37202M	-2.66742M	-1.92415M	-0.73430M	-6.61429M
Change in cash	-4.44904M	4.16M	-0.95448M	3.25M	0.11M
Begin period cash flow	12.51M	8.35M	9.30M	6.06M	5.95M
End period cash flow	8.06M	12.51M	8.35M	9.30M	6.06M
Total cash from operating activities	-3.70388M	-0.97517M	-0.19761M	4.04M	3.08M
Issuance of capital stock	4.26M	-	-	-	-
Depreciation	0.84M	0.84M	0.05M	0.16M	0.28M
Other cashflows from investing activities	-	-	-	-	-
Dividends paid	-	-	-	0.00000M	0.25M
Change to inventory	0.25M	0.25M	0.25M	0.25M	-
Change to account receivables	-2.06588M	-	-	1.38M	-2.13801M
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	-0.66005M	-0.66005M	-0.66005M	-0.66005M	0.00300M
Change to netincome	0.03M	0.42M	0.93M	1.67M	5.59M
Capital expenditures	0.06M	0.06M	0.06M	0.06M	0.09M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	-0.20620M	1.27M	1.29M	4.35M	3.83M
Stock based compensation	1.20M	0.24M	0.02M	0.10M	-
Other non cash items	-5.65086M	-	-	-	-
Free cash flow	-3.75914M	-0.97517M	-0.12805M	4.00M	2.98M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
SGMD Salona Global Medical Device Corp	- -%	-	-	-	0.31	0.93	1.13	-3.3546
TLT Theralase Technologies Inc.	-0.005 2.08%	0.23	-	-	90.07	82.51	90.31	-12.0585
CNVI Conavi Medical Corp.	-0.005 2.13%	0.23	-	-	66.65	-	95.30
PINK Perimeter Medical Imaging AI Inc	-0.015 5.00%	0.28	4.13	-	18.78	11.34	20.22	-2.5521
CHER Cheelcare Inc.	- -%	1.60	-	-	20.92	106.42	21.26

Reports Covered

View All

Profile

Salona Global Medical Device Corporation, through its subsidiaries, engages in the development, production, and sale of medical devices and products in the United States. The company's medical devices are used for pain management and physical therapy treatments, including cold/hot therapy products, neuromuscular electrical stimulation devices, transcutaneous electrical nerve stimulation devices, and ultrasound treatment devices. It also offers wearable technology and products that are used to enhance physical stability. The company was formerly known as Brattle Street Investment Corp. and changed its name to Salona Global Medical Device Corporation in December 2020. Salona Global Medical Device Corporation is headquartered in Carlsbad, California.

Salona Global Medical Device Corp

3330 Caminito Daniella, Del Mar, CA, United States, 92014

800 760 6826
https://www.salonaglobal.com
Employees : 144

Key Executives

Name	Title	Year Born
Mr. Leslie H. Cross	Exec. Chairman & Corp. Sec.	1951
Mr. Luke T. Faulstick	CEO & Director	1964
Dr. Rick Greenwald	Co-Founder & Pres of Simbex	NA
Jeffrey Chu	Exec. Officer	NA
Mr. Dennis T. Nelson	Chief Financial Officer	1973
Mr. Scott Rogow	VP of Sales & Marketing	NA
Mr. Jethro Rothe-Kushel	VP of Capital Markets & Financial Communications	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.